EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanogel Integrated Zwitterionic Injectable Hydrogel with Sequential Drug‐Releasing Capability for the Programmable Repair of Spinal Cord Injury

Zhijian Wei, Susu Huang, Wencan Zhang, Jiayao Wen, Xiaolong Zhou, Wei He, Xiaoye Yang, Haifeng Wang, Guangxi Zhai, Bin Shi, Lin Jin iD, Dachuan Wang und 2 weitere

Advanced Science · 2026-01 · 13 (6)

DOI: 10.1002/advs.202510976 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 12.11.2025. Verfasst von Zhijian Wei und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Qilu Hospital, Shandong University Centre for Orthopaedics, Advanced Medical Research Institute, Shandong University, Jin…. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Hydrogels, Nanogels, Drug Delivery Systems. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Special Project-Major New Drug Creation, China Postdoctoral Science Foundation, Tianjin Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal cord injury (SCI), a highly disabling injury to the central nervous system, has a complex and sequential pathogenesis. Traditional multiple‐delivery systems rely on a physical mix of nanoparticles or drugs in hydrogels, which lacks the controllability of the drug. To solve these problems, an integrative hydrogel system cross‐linked with a Per‐g‐PSB nanogel is designed. Dendritic macromolecular nanogels (Per‐g‐PSB) could not only act as cross‐linkers to adjust the hydrogel mechanical properties but also form a dynamic network (Dex/Per‐g‐PSB hydrogel). Most importantly, a large amount of charge could lead to a significant sustained release via electrostatic interactions. The hydrogel platform (Mel/Ibu@D/P‐g‐PSB) realizes the sequential release of melatonin and ibuprofen by different mechanisms. Melatonin is first released by diffusion and exhibits significant neuroprotective effects during the acute phase by downregulating the expression of inflammatory cytokines. Ibuprofen is released in the second stage due to strong electrostatic interactions, and it reduces RhoA signaling activation by blocking the ROCK pathway in the subacute phase, which reduces the deleterious cascade reaction after spinal cord injury. These results show that the ion‐sensitive hydrogel platform with sequentially releasing drug effects, combining anti‐inflammatory effects and blocking the ROCK pathway, shows excellent repair of SCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesHydrogelsNanogelsDrug Delivery SystemsAnimalsDrug LiberationMelatoninIbuprofenMiceRatsNeuroprotective Agents

Stichwörter der Autor:innen

hydrogelinjectablemelatoninspinal cord injuryzwitterionic

Substanzen

HydrogelsNanogelsMelatoninIbuprofenNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Orthopaedics, Qilu Hospital, Shandong University Centre for Orthopaedics, Advanced Medical Research Institute, Shandong University, Jinan, Shandong, 250012, China.
  • NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), State Key Laboratory of Discovery and Utilization of Functional Components in T…
  • Department of Pharmacy, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
  • Department of Orthopaedics, The Second Hospital of Shandong University, No. 247 Beiyuan Street, Tianqiao District, Jinan, 250033, China.
  • Neck-Shoulder and Lumbocrural Pain Hospital of Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Sciences, No. 18877, Jingshi Road, Lixia District, Jinan, 518873, China.
  • International Joint Research Laboratory for Biomedical Nanomaterials of Henan, Zhoukou Normal University, No. 6, Middle Section of Wenchang Avenue, Chuanhui District, Zhoukou, 466001, China.

ORCID-Profile: Lin Jin

Förderung

  • National Science and Technology Major Special Project-Major New Drug Creation
  • China Postdoctoral Science Foundation
  • Tianjin Science and Technology Project
  • Hebei Provincial Health Commission
  • Hebei Natural Science Foundation
  • Beijing-Tianjin-Hebei Basic Research Cooperation Project
  • Taishan Scholar Foundation of Shandong Province

Zitieren

APA

Wei, Z., Huang, S., Zhang, W., Wen, J., Zhou, X., He, W., Yang, X., Wang, H., Zhai, G., Shi, B., Jin, L., Wang, D., Feng, S., & Ye, L. (2026). Nanogel Integrated Zwitterionic Injectable Hydrogel with Sequential Drug‐Releasing Capability for the Programmable Repair of Spinal Cord Injury. Advanced Science, 13(6). https://doi.org/10.1002/advs.202510976

Vancouver

Wei Z, Huang S, Zhang W, Wen J, Zhou X, He W, et al. Nanogel Integrated Zwitterionic Injectable Hydrogel with Sequential Drug‐Releasing Capability for the Programmable Repair of Spinal Cord Injury. Advanced Science. 2026;13(6). doi:10.1002/advs.202510976

BibTeX
@article{Wei2026,
  author = {Wei, Zhijian and Huang, Susu and Zhang, Wencan and Wen, Jiayao and Zhou, Xiaolong and He, Wei and Yang, Xiaoye and Wang, Haifeng and Zhai, Guangxi and Shi, Bin and Jin, Lin and Wang, Dachuan and Feng, Shiqing and Ye, Lei},
  title = {Nanogel Integrated Zwitterionic Injectable Hydrogel with Sequential Drug‐Releasing Capability for the Programmable Repair of Spinal Cord Injury},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {6},
  doi = {10.1002/advs.202510976}
}
Kostenlos starten →